The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer

Published:2019-10-15 Issue:4 Volume:51 Page:1411-1419
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Go Se-Il,Ko Gyung Hyuck,Lee Won Sup,Lee Jeong-Hee,Jeong Sang-Ho,Lee Young-Joon,Hong Soon Chan,Ha Woo Song

Funder

National Research Foundation of Korea

Ministry of Health and Welfare

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2018-663.pdf

Reference32 articles.

1. Population-Based Regional Cancer Incidence in Korea: Comparison between Urban and Rural Areas

2. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013

3. Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation

4. CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of concurrent evaluation of HER2 gene amplification and p53 and Ki67 expression in gastric cancer tissues;Clinical and Translational Oncology;2024-06-22

2. Impact of Alcian blue and periodic acid Schiff expression on the prognosis of gastric signet ring cell carcinoma;World Journal of Gastrointestinal Oncology;2024-03-15

3. The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach;Journal of Gastrointestinal Cancer;2024-02-27

4. Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway;Frontiers in Bioscience-Landmark;2024-01-19

5. The Role of MiR-711 in Regulating the Stemness and EMT of Gastric Cancer Stem-Like Cells;J BIOL REG HOMEOS AG;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3